A3N326 AF NFT

DNA-directed RNA polymerase subunit beta'

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeib67nrefhwrflqaak5nvel6te6c4xnwmzlrsdedaa7d3g55dx6c2i/metadata.json
IPFS of structure file: 
bafybeid6gq7qjh5veeiek357jxnrhm3fig5joobh6rl32hsvhxrkwoi2ry/AF-A3N326-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xE0f638aAeC0fC873fF063AFC3F62b973dEc92BcB
First NFT owner address (bech32): 
genesis1urmr32hvply88lcx8t7r7c4ew00vj27tk48u9k
Current NFT ID #388152 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
388152
Accession (UniProt):
A3N326
Name::
DNA-directed RNA polymerase subunit beta'
Experimental Method:
Predicted structure
Sequence source:
Actinobacillus pleuropneumoniae serotype 5b (strain L20)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT A3N326 research and analysis (ICN3D with VR)

FASTA sequences

>sp|A3N326|RPOC_ACTP2 DNA-directed RNA polymerase subunit beta' OS=Actinobacillus pleuropneumoniae serotype 5b (strain L20) OX=416269 GN=rpoC PE=3 SV=1 MKDLVKFLKAQSKSNDDFDVIKIGLASPDKIRSWSFGEVKKPETINYRTFKPERDGLFCARIFGPVKDYECLCGKYKRLRHRGVICEKCGVEVTQTKVRRDRMGHIELACPVAHIWFLKSLPSRIGLILDMPLRDIERVLYFESYVVTEPGMTDLEKNQLLTEEQFLDAEERWGDEFEAKMGAEGIQALLRDMDLEHQCEMMREELQETNSETKRKKITKRLKLLEAFQQSGNKPEWMVMTVLPVLPPDLRPLVPLDGGRFATSDLNDLYRRVINRNNRLKRLLDLVAPDIIVRNEKRMLQESVDALLDNGRRGRAITGSNKRPLKSLADMIKGKQGRFRQNLLGKRVDYSGRSVITVGPYLHLHQCGLPKKMALELFRPFIYSKLESRGIASTIKAAKKMVEREEPIVWDILAEVIREHPILLNRAPTLHRLGIQAFEPILIEGKAIQLHPLVCAAFNADFDGDQMAVHVPLTLEAQLEARALMMSTNNVLSPASGDPIIVPSQDVVLGLYYMTREKVNAKGEGMYFLDPREAEKAYRTGQAELHARVKVRITEHVKNEAGELVAETKLLDTTIGRAILWMIAPKGMPFKVFNQTLGKKAISKLINESYRRLGLKESVILADQIMYTGFAYAARSGASVGIDDMVIPAQKHEIIRAAEAEVAEIQEQFNSGLVTAGERYNKVIDIWAAANERVAKAMMENLSTEEVINREGNPEKQASFNSIFMMADSGARGSAAQIRQLAGMRGLMARPDGSIIETPITANFREGLNVLQYFISTHGARKGLADTALKTANSGYLTRRLVDVAQDLVITEDDCGTHEGIVMTPLIEGGDVKEALRDRVLGRVVAEDVLKPGTEEVLIPRNTLIDEKWCDVIDAESVDVIKVRSVVTCNTDFGVCAKCYGRDLARGHLINQGEAVGVIAAQSIGEPGTQLTMRTFHIGGAASAAAKESSIQVKNAGTIKLTNAKFVTNKEGKIVLTSRNTELTVIDTFGRTKENYKVPYGAVLSKNDGAEVAVGEVVANWDPHTMPVISEVSGRIQFSDIVDGLTVTRQTDELTGLSSIVVQDVGERATAGKDLRPALRLVDAQGNDILIPSTDVAAQYFLPGKAIVTLDDGAEIEVGEALARIPQESVGTKDITGGLPRVADLFEARKPKEPAILAEISGIVSFGKETKGKRRLVITPAEGEAFEEMIPKWRQLNVFEGEMVQRGDVISDGAETPHDILRLRGVHAVTDYIVNEVQEVYRLQGVKINDKHIEVIVRQMLRKAVITNAYDSEFLEGEQVEVSRVKIANRKRAEEGKPLVEFERELLGITKASLATESFISAASFQETTRVLTEAAVAGKRDELRGLKENVIVGRLIPAGTGFAYHQNRAKKRNQQEQAVAFEAPVEKLTGSQPMLISKRNSNSLQTMQLKA